MAY 18, 2010 5:55pm ET

Related Links

Final Rule for Unique Medical Device Identifier Could Come Soon
June 17, 2013
FDA Warns of Malware on Medical Devices
June 17, 2013
Lucile Packard Notifies 12,900 Following Laptop Theft
June 14, 2013
New GE Product Monitors Medical Device Networks
May 31, 2013
Tablets to Outsell Portable PCs in 2013
May 30, 2013
Blackstone Pulls Out of Dell Bid on Rapidly Falling PC Sales
April 19, 2013
Dell Buyout Seen Triggering Investor Lawsuits Over CEO Role
February 5, 2013

FDA Approves Menstrual Treatment

Print
Reprints
Email

The Food and Drug Administration has approved the Genesys HTA System of Boston Scientific Corp. for treatment of menorrhagia, or abnormally heavy and prolonged menstrual bleeding.

The system includes a hardware and software unit that controls the procedure through tubing and a sheath of heated saline solution to the endometrial (interior) lining of the uterus.

The procedure can be done in a hospital outpatient setting under general anesthesia or a physician office using a local anesthetic.

An estimated 10 million women in the United States have menorrhagia, according to the Natick, Mass.-based vendor. More information is available at bostonscientific.com.

--Joseph Goedert

 

Comments (0)

Be the first to comment on this post using the section below.

Add Your Comments:
You must be registered to post a comment.
Not Registered?
You must be registered to post a comment. Click here to register.
Already registered? Log in here
Please note you must now log in with your email address and password.
Twitter
Facebook
LinkedIn

There are well over 400 accountable care organizations in the nation now and about two dozen self-sustaining health information exchanges.

Login  |  My Account  |  White Papers  |  Web Seminars  |  Events |  Newsletters |  eBooks
FOLLOW US
Already a subscriber? Log in here
Please note you must now log in with your email address and password.